Medication-Assisted Treatment (MAT) Providers help individuals recover from opioid use disorder by combining evidence-based medications with counseling and behavioral therapies. MAT is a proven, holistic approach to addiction treatment that targets both the physical and psychological aspects of addiction. Medications such as methadone, buprenorphine, and naltrexone are used to alleviate withdrawal symptoms, reduce cravings, and block the effects of opioids, while therapy helps individuals develop the coping strategies needed for long-term recovery. MAT providers work closely with each patient to create a personalized treatment plan that best addresses their unique needs and challenges.
These professionals work in various settings, including outpatient treatment centers, rehabilitation clinics, and hospitals, often collaborating with addiction specialists, therapists, and social workers to provide comprehensive care. MAT providers not only prescribe and monitor medications but also guide patients through their recovery process, offering support, education, and relapse prevention strategies. By combining medication with counseling and support, MAT providers significantly increase the likelihood of successful long-term recovery. Their expertise in managing both the medical and emotional aspects of addiction helps individuals regain control of their lives and pursue lasting sobriety. Through MAT, individuals are empowered to build a foundation for lasting recovery and a healthier future.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States